A phase 1/2 clinical trial of quaratusugene ozeplasmid gene therapy and atezolizumab maintenance therapy in patients with extensive stage small cell lung cancer (ES-SCLC).

Authors: Bo Wang, Kartik Konduri, Robert M. Jotte, Donald A. Richards, Rachel E. Sanborn, Alexander I. Spira, David Michael Waterhouse, Katherin Combs, Jacqueline Opiola, Mark S. Berger, Daniel Morgensztern

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps8126

Source: Full article

---

Abstract

TPS8126